Hormone Replacement Therapy and the Risk of Breast Cancer Recurrence in Women With Previous Early Stage Breast Cancer
Status:
Completed
Trial end date:
2004-02-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Hormone replacement therapy is effective for relieving symptoms of menopause. It
is not yet known if hormone replacement therapy increases the risk of breast cancer
recurrence in women previously treated for early stage breast cancer.
PURPOSE: Randomized phase III trial to determine the risk of breast cancer recurrence in
women with previous early stage breast cancer who are receiving hormone replacement therapy
for menopause symptoms.
Phase:
Phase 3
Details
Lead Sponsor:
Regional Oncologic Center
Collaborators:
European Organisation for Research and Treatment of Cancer - EORTC International Breast Cancer Study Group Scandinavian Breast Group